NCT03328559

Kinetics of Circulating Tumoral Cells in Bronchial Primitive Cancer

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Fondation Hôpital Saint-Joseph · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The pronostic value of Circulating Tumoral Cells(CTC) 's dosage by the method ISET® (tumoral cell isolation by size) in patients with bronchial cancer was previously demonstrated. However, no kinetic study was ever realized to study the value of the CTC as predictive indicator of answer to the therapy. This project plans to study patients in an early stage and patients at advance stage locally moved forward or metastatic of the disease by evaluation of the presence and the number of CTC before every cure. This collaborative and original study should allow to refine the diagnoses of answer and to plan the possible relapses what would allow a premature institution of the treatment.

Conditions

• Bronchial Cancer

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	ISET® - Isolation by Size of Tumor cells	early stage bronchial cancer patient will have a blood collection
DIAGNOSTIC_TEST	ISET® - Isolation by Size of Tumor cells	advanced stage bronchial cancer patient will have a blood collection

Timeline

• Start date: 2016-03-07
• Primary completion: 2018-11-30
• Completion: 2021-08-20
• First posted: 2017-11-01
• Last updated: 2021-08-23

Locations

1 site across 1 country: France